IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 11 holdings | $8.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$8.7M767,02698.5%
Spdr Series Trust(XBI)PutS&P BIOTECH78464A870$38.1K500,0000.4%
Merus N VCOMN5749R100$18.5K1,038,7460.2%
Uniqure NV(QURE)CallSHSN90064101$15.7K400,0000.2%
Uniqure NV(QURE)SHSN90064101$15.4K391,1990.2%
Spero Therapeutics Inc(SPRO)COM84833T103$12.2K1,154,3560.1%
Pieris Pharmaceuticals IncCOM720795103$10.1K2,958,2430.1%
Galapagos NV(GLPG)SPON ADR36315X101$8.7K56,8400.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$8.6K951,5270.1%
Proqr Thrapeutics N VSHS EURON71542109$4.8K831,6610.1%
Fate Therapeutics Inc(FATE)COM31189P102$1.1K72,2730.0%